Cross-Border Counterfeit Crisis: The Ozempic Scam Exposed

The illegal trade in counterfeit Ozempic pens is endangering lives worldwide, with criminals exploiting weak regulations and corrupt connections to circulate fake drugs. A Texas man's purchase of fake Ozempic in Mexico has highlighted the growing problem and the urgent need for stricter global measures to combat drug counterfeiting.

Drew, a 36-year-old from San Antonio, Texas, drove over 250 miles to Mexico in December to buy cheaper Ozempic for weight loss. Upon returning, he discovered the pens were counterfeit. His experience is emblematic of a broader issue plaguing drug manufacturing, with criminal organizations distributing dangerous fake medications.

Pharmaceutical companies like Novo Nordisk mark drug batches with unique identifiers. The fake pens Drew bought carried a batch number intended for Egypt, highlighting potential internal leaks or reliance on scanning technologies by criminals. These inconsistencies are worsened by inconsistent global drug regulations.

Inadequate checks have led to hospitalizations in four countries, with fake Ozempic pens turning up in at least 10 countries. The demand, driven by global obesity rates, has fueled counterfeit operations, complicating efforts by authorities to mitigate the risks. Identifying leaders of these operations remains a substantial challenge.

(With inputs from agencies.)